Literature DB >> 32712505

Difficult-to-treat pathogens significantly reduce infection resolution in periprosthetic joint infections.

Matthias D Wimmer1, Gunnar T R Hischebeth2, Thomas M Randau1, Martin Gathen1, Frank A Schildberg1, Frank S Fröschen1, Hendrik Kohlhof1, Sascha Gravius3.   

Abstract

Periprosthetic joint infection (PJI) is a feared complication after arthroplasty. Our hypothesis was that PJI caused by difficult-to-treat (DTT) pathogens has a worse outcome compared with non-DTT PJI. Routine clinical data on 77 consecutive patients with confirmed PJI treated with 2-stage exchange arthroplasty were placed in DTT and non-DTT PJI groups and analyzed. The main outcome variable was that the patient was definitively free of infection after 2 years. We found definitive infection resolution in 31 patients in the DTT group (68.9%) and 28 patients (87.5%) in the non-DTT group (P < 0.05). The necessity for revision surgery until assumed resolution of infection was significantly more frequent in the DTT group with 4.72 ± 3.03 operations versus 2.41 ± 3.02 operations in the non-DTT group (P < 0.05). PJI caused by DTT bacteria is associated with significantly higher numbers of revision operations and significantly inferior definitive infection resolution.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Arthroplasty; DTT; Difficult-to-treat; Infection; Periprosthetic joint infection; Revision

Mesh:

Substances:

Year:  2020        PMID: 32712505     DOI: 10.1016/j.diagmicrobio.2020.115114

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  6 in total

Review 1.  [Strategic approach in periprosthetic joint infections].

Authors:  Peter Savov; Max Ettinger; Henning Windhagen; Mohamed Omar; Lars-Rene Tuecking
Journal:  Unfallchirurg       Date:  2021-12-10       Impact factor: 1.000

Review 2.  Ways to Improve Insights into Clindamycin Pharmacology and Pharmacokinetics Tailored to Practice.

Authors:  Laura Armengol Álvarez; Greet Van de Sijpe; Stefanie Desmet; Willem-Jan Metsemakers; Isabel Spriet; Karel Allegaert; Jef Rozenski
Journal:  Antibiotics (Basel)       Date:  2022-05-21

3.  Megaprostheses for the revision of infected hip arthroplasties with severe bone loss.

Authors:  Nicola Logoluso; Francesca Alice Pedrini; Carlo Luca Romanò; Antonio Virgilio Pellegrini; Ilaria Morelli; Elena De Vecchi
Journal:  BMC Surg       Date:  2022-02-25       Impact factor: 2.102

4.  [Treatment of bone and periprosthetic infections with bacteriophages : A systematic review].

Authors:  Nike Walter; Li Deng; Christoph Brochhausen; Volker Alt; Markus Rupp
Journal:  Orthopade       Date:  2021-09-09       Impact factor: 1.087

5.  A mean 4-year evaluation of infection control rates of hip and knee prosthetic joint infection-related revision arthroplasty: an observational study.

Authors:  Bruce Van Dijk; F Ruben H A Nurmohamed; J Fred F Hooning van Duijvenbode; Ewout S Veltman; Rob J Rentenaar; Harrie Weinans; H Charles Vogely; Bart C H Van der Wal
Journal:  Acta Orthop       Date:  2022-07-13       Impact factor: 3.925

6.  Microbiological Profiles of Patients with Periprosthetic Joint Infection of the Hip or Knee.

Authors:  Frank Sebastian Fröschen; Thomas Martin Randau; Alexander Franz; Ernst Molitor; Gunnar Thorben Rembert Hischebeth
Journal:  Diagnostics (Basel)       Date:  2022-07-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.